Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00161772 | Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years. | PHASE2 | COMPLETED | - | — | — | Mar 1, 2002 | Aug 1, 2002 | May 21, 2015 | 23 | Austria, Germany |
| NCT00161798 | Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years. | PHASE2 | COMPLETED | - | — | — | Sep 1, 2001 | Mar 1, 2002 | May 21, 2015 | 23 | Germany |
| Name | Type | Description |
|---|---|---|
| Tick-borne Encephalitis Vaccine | BIOLOGICAL | - |
Inclusion Criteria: Male and female children will be eligible for participation in this study if: * they are 1 year (from the 1st birthday) to 6 years (to the last day before the 6th birthday) old; * they are clinically healthy; * their legal representative understands the nature of the study, agr...